Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
By S. Yusuf, S. Hawken, S. Ôunpuu, T. Dans, Á. Avezum, F. Lanas, M. McQueen, A. Budaj, P. Pais, J. Varigos and 1 more. The Lancet, 2004
11,912 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/10dabc382cb25662230251ff42e257d03feaefee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- P. Ridker
- Michael J. Pencina
- Ralph B. D’Agostino
- Ramachandran S. Vasan
- Julian F. Thayer
- Philippe van de Borne
- N. Rifai
- I. Graham
In Pediatrics, Perinatology and Child Health
- I. Graham
- M. Ezzati
- T. Ivanova
- Julian F. Thayer
- Robin Room
- George Davey Smith
- Stephen Burgess
- J. Bowden
Citations in the corpus
- Pathophysiology of Type 2 Diabetes Mellitus (2020, neutral): “As an example, the best predictor of risk of myocardial infarction at the population level in the INTERHEART study was the apolipoprotein (apo) B100/apoA-I ratio, reflecting the correlation between all apoB (atherogenic lipoproteins) and HDL (representing classically anti-atherogenic particles) [235”
- International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “dial infarction in the INTERHEART study.(18) Overall, these findings high-”
- Immunity, atherosclerosis and cardiovascular disease (2013, background): “and CVD [18,19], the exact mechanisms by which smoking could cause inflammation in the arteries are not fully”
- Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018, neutral): “Data from a large case–control study (INTERHEART study) suggest a beneficial effect of dietary antioxidants against coronary heart disease (46).”
- Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005, background): “In this regard, there was virtually no use of statin therapy at the time of enrollment into the WHS and overall usage rates remained very low at all points of follow-up reflecting the low-risk nature of this cohort.19 However, in the Air Force Texas Coronary Atherosclerosis Prevention Study (AFCAPS/”
- Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. (2008, positive): “In particular, the apolipoproteins and abdominal obesity are much stronger predictors of the risk of MI than blood lipid levels and body mass index.(7,10) Furthermore, the Framingham analysis did not include dietary intake,”